Second Opinion Centers for Liver Cancer
Expert multidisciplinary reviews using BCLC 2024 staging guidelines for hepatocellular carcinoma (HCC).
Why Get a Second Opinion?
Up to 30% of initial HCC diagnoses are revised upon expert review using BCLC 2024 criteria.
A second opinion from a specialized liver cancer center can significantly impact treatment planning and outcomes. BCLC 2024 incorporates new biomarkers, imaging modalities, and systemic therapies that may not be available at local institutions.
Multidisciplinary tumor boards include hepatologists, oncologists, interventional radiologists, and transplant surgeons who collectively determine optimal management based on the latest evidence.
BCLC 2024 Key Updates
New biomarkers: AFP-L3, PIVKA-II, GPC3
Expanded systemic options: Atezolizumab + Bevacizumab as standard
Refined locoregional criteria: TACE eligibility
Leading Second Opinion Centers
International institutions with BCLC 2024 expertise
MD Anderson Cancer Center
Houston, TX, USA
- Weekly HCC tumor board
- BCLC 2024 principal investigators
- 48-hour virtual review
Beijing Cancer Hospital
Beijing, China
- Asia-Pacific BCLC reference center
- ctDNA + imaging integration
- Chinese + English reports
National Cancer Center Japan
Tokyo, Japan
- JSH-BCLC harmonization
- AI-assisted staging
- Clinical trial matching
Second Opinion Process
From submission to personalized treatment plan
Submit Records
Upload imaging (MRI/CT), pathology, blood tests, and current treatment plan via secure portal.
Expert Review
Case presented to multidisciplinary tumor board using BCLC 2024 criteria within 24 hours.
Receive Report
Detailed second opinion with staging, treatment options, and clinical trial eligibility in 48 hours.
Request Your Second Opinion Today
Upload your medical records for expert BCLC 2024 review within 48 hours.